Volitionrx LTD Schedule 13G passive stakes

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 8.72% in VolitionRx Ltd., holding 9,380,425 shares.

Armistice Capital, LLC and Steven Boyd have updated their beneficial ownership in VolitionRx Ltd., reporting a collective stake of 9.99% as of March 31, 2025.

Lagoda Investment Management, L.P. has increased its beneficial ownership in VolitionRX Ltd to 11.3% of common stock as of June 30, 2025.

Armistice Capital, LLC and Steven Boyd have disclosed a combined beneficial ownership of 9.99% of VolitionRx Ltd.'s common stock, totaling 9,804,352 shares, as of March 31, 2025.

Lagoda Investment Management, L.P. has filed an amended Schedule 13G, revealing a significant passive beneficial ownership of 10.56% in VolitionRX Ltd.

Armistice Capital, LLC and Steven Boyd have reported a combined beneficial ownership of 9.99% of VolitionRx Ltd.'s common stock as of December 31, 2024.

Lagoda Investment Management, L.P. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.18% in VolitionRX Limited as of December 31, 2024.